Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Nicola J Mason"'
Autor:
Guannan Wang, Ming Wu, Amy C Durham, Enrico Radaelli, Nicola J Mason, XiaoWei Xu, David B Roth
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229728 (2020)
Angiosarcoma (AS) is a rare neoplasm with limited treatment options and a poor survival rate. Development of effective therapies is hindered by the rarity of this disease. Dogs spontaneously develop hemangiosarcoma (HSA), a common, histologically sim
Externí odkaz:
https://doaj.org/article/e4c523450808497196677c329fa6a380
Autor:
Guannan Wang, Ming Wu, Martha A Maloneyhuss, John Wojcik, Amy C Durham, Nicola J Mason, David B Roth
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188667 (2017)
Angiosarcomas (AS) are rare in humans, but they are a deadly subtype of soft tissue sarcoma. Discovery sequencing in AS, especially the visceral form, is hampered by the rarity of cases. Most diagnostic material exists as archival formalin fixed, par
Externí odkaz:
https://doaj.org/article/7ac3c875436445e4b9d74081a70e7cae
Autor:
Sho Yoshimoto, Ayano Kudo, Antonia Rotolo, Kay Foos, Lauren Olenick, Satoshi Takagi, Nicola J. Mason
Publikováno v:
iScience, Vol 27, Iss 9, Pp 110863- (2024)
Summary: Chimeric antigen receptor (CAR) T cell therapy has achieved unprecedented clinical outcomes in patients with relapsed/refractory B cell leukemias; however, response rates in patients with large B cell lymphoma (LBCL) are less impressive. Exp
Externí odkaz:
https://doaj.org/article/4ae98bc49bd04a9e85d8374cbd88ff41
Autor:
Georges Habineza Ndikuyeze, Anita Gaurnier-Hausser, Reema Patel, Albert S Baldwin, Michael J May, Patrick Flood, Erika Krick, Kathleen J Propert, Nicola J Mason
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e95404 (2014)
Activated B-Cell (ABC) Diffuse Large B-Cell Lymphoma (DLBCL) is a common, aggressive and poorly chemoresponsive subtype of DLBCL, characterized by constitutive canonical NF-κB signaling. Inhibition of NF-κB signaling leads to apoptosis of ABC-DLBCL
Externí odkaz:
https://doaj.org/article/4e5bee67ecdb4a43b058c8a7e1188110
Autor:
Karin U Sorenmo, Erika Krick, Christina M Coughlin, Beth Overley, Thomas P Gregor, Robert H Vonderheide, Nicola J Mason
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e24167 (2011)
Cell-based active immunotherapy for cancer is a promising novel strategy, with the first dendritic cell (DC) vaccine achieving regulatory approval for clinical use last year. Manufacturing remains arduous, especially for DC vaccines, and the prospect
Externí odkaz:
https://doaj.org/article/dce81d50212b4062ae774bc9045000da
Autor:
Sho Yoshimoto, Nicholas Chester, Ailian Xiong, Enrico Radaelli, Hong Wang, Marc Brillantes, Gayathri Gulendran, Patrick Glassman, Don L. Siegel, Nicola J. Mason
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTPD-1 checkpoint inhibitors have revolutionized the treatment of patients with different cancer histologies including melanoma, renal cell carcinoma, and non-small cell lung carcinoma. However, only a subset of patients show a dramatic clinica
Externí odkaz:
https://doaj.org/article/e2cc3ba3c4cc456f979a67ebfed7ed7f
Autor:
Ashley M. Fuller, Ann DeVine, Ileana Murazzi, Nicola J. Mason, Kristy Weber, T. S. Karin Eisinger-Mathason
Publikováno v:
Cellular Oncology. 45:1277-1295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e917853fc3508c58577a74c348eb2052
https://doi.org/10.1007/s13402-022-00717-1
https://doi.org/10.1007/s13402-022-00717-1
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
Signalment and primary tumor characteristics of dogs with pre-existing metastatic disease treated on a compassionate care basis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c0a13697caf6da67e1f545060fe6c3
https://doi.org/10.1158/1078-0432.22465176
https://doi.org/10.1158/1078-0432.22465176
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
Purpose: Recombinant Listeria vaccines induce tumor-specific T-cell responses that eliminate established tumors and prevent metastatic disease in murine cancer models. We used dogs with HER2/neu+ appendicular osteosarcoma, a well-recognized spontaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e4c99c97349fb90c02df0a5cfe285e
https://doi.org/10.1158/1078-0432.c.6525942
https://doi.org/10.1158/1078-0432.c.6525942
Autor:
Yvonne Paterson, Margie Huebner, Anu Wallecha, Anita Gaurnier-Hausser, Danielle Laughlin, Falon Gray, Julie B. Engiles, Josephine S. Gnanandarajah, Nicola J. Mason
ADXS31-164 does not adversely affect cardiac function.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642b0343199baeae23a44146f9f35647
https://doi.org/10.1158/1078-0432.22465182.v1
https://doi.org/10.1158/1078-0432.22465182.v1